Roadshow
Pharmacogenomics DNA genotype detection kits
Medication remains our most critical tool for patient recovery. However, the traditional "one-size-fits-all" approach to prescribing often leads to costly trial-and-error, treatment delays, and dangerous adverse reactions.
As a leading manufacturer of advanced diagnostic solutions, we developed our Pharmacogenomics (PGx) Testing Kits to bridge the gap between complex genetics and clinical action. We manufacture high-precision, scalable testing kits to make personalized medicine safer, faster, and more efficient.
Join us at BIO 2026, June 22–25 in San Diego!
Taipei’s biotech innovators will showcase cutting-edge solutions and services at the Taiwan Pavilion. Visit Booth #2621 to explore partnership opportunities, meet leading Taipei companies, and discover how Taipei is advancing the future of biotechnology.
Let’s connect at BIO 2026 — see you in San Diego!
#BIO2026 #Taipei #TaiwanPavilion
PG5801 Detection Kit (HLA-B*58:01)
HLA-B*58:01 genetic test can prevent a life-threatening hypersensitivity reaction. This specific allele is the strongest known predictor for Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
Screening high-risk patients before their first dose allows clinicians to confidently identify who can safely take allopurinol.
PG3101 Detection Kit (HLA-B*31:01)
Enhance the safety profile and market confidence of your carbamazepine therapies by integrating our high-precision HLA-B*31:01 companion diagnostic into your product ecosystem. With regulatory agencies like the FDA and EMA highlighting the strong link between this biomarker and drug-induced Severe Cutaneous Adverse Reactions (SCAR)—such as DRESS syndrome and Stevens-Johnson Syndrome—offering this genetic screen directly mitigates prescriber anxiety across diverse patient populations.
PG5701 Detection Kit (HLA-B*57:01)
Accelerate the commercial growth and clinical trust of your abacavir-based therapies by integrating our gold-standard HLA-B*57:01 companion diagnostic into your HIV portfolio. With global regulatory bodies mandating genetic screening prior to initiation to completely eliminate the risk of life-threatening Abacavir Hypersensitivity Syndrome (AHS), a reliable, high-specificity test is essential for securing market access and prescriber confidence.
PG27 Detection Kit (HLA-B27)
As a critical biomarker fundamentally linked to spondyloarthritides, especially Ankylosing Spondylitis (AS), rapid HLA-B27 identification allows rheumatologists and ophthalmologists to bypass years of diagnostic delay and confidently initiate advanced therapies sooner.
PG1639 Detection kit (VKORC1), PG0430 Detection kit (CYP2C9*2), PG1075 Detection Kit (CYP2C9*3)
Warfarin is a common anticoagulant for cardiovascular disease. However, the maintenance dosage varies for different people. Moreover, wrong dosage may cause severe bleeding or clotting complications.
Combined results of PG1639, PG0430 and PG1075 could provide a scientific suggestion to optimize the Warfarin dosage.
PG0681 Detection Kit (CYP2C19*2), PG0636 Detection Kit (CYP2C19*3)
Clopidogrel is one of the most widely trusted blood thinners in the world, designed to prevent dangerous blood clots and protect you from future heart attacks or strokes. However, Clopidogrel is an inactive prodrug. It requires a specific liver enzyme—CYP2C19—to activate it.
With testing results of PG0681 and PG0636, patients could be advised for the proper dose of Clopidogrel to maximize effectiveness.
- #Allopurinol
- #Carbamazepine
- #Abacavir
- #Ankylosing Spondylitis
- #Warfarin
- #Clopidogrel
- #HLA typing
- #Cytochrome P450
- #Pharmacogenomics
- #Precision medicine
- Established 2005
- Company Pharmigene Inc
- Telephone +886-2-2798-5885
- Email service@pharmigene.com
- Address 7 F., No. 302, Jianguo 1st Rd., Xinzhuang Dist., New Taipei City 242047, Taiwan (R.O.C.)
Established in 2005, Pharmigene Inc. is a leading biotechnology company specializing in pharmacogenomic testing. We hold exclusive global licenses from Academia Sinica for patents related to genetic testing for Warfarin and other critical medications such as Carbamazepine and Allopurinol. Leveraging these proprietary technologies, we have developed advanced diagnostic products and tools that have secured comprehensive technical patent certifications across numerous countries worldwide, including the USA, Europe, New Zealand, Australia, Japan, China, India, and Southeast Asia.Headquartered in Taiwan, Pharmigene operates a state-of-the-art R&D center and maintains stringent quality management systems. Our commitment to excellence is underscored by our certifications, including international ISO 13485, Taiwan QMS (GMP), and South Korea KGMP, ensuring the highest standards in medical device manufacturing and diagnostic solutions.
• Pharmacogenomic Testing
• Manufacturing: One-Stop IVD CDMO Services Compliant with International Standards
• Molecular Diagnostic Reagents: Develop Precision Medical Testing Products
• Agency Sales: Research Tools and Platforms to Support Clinical and Research Needs